[1]
Rizqiana Arum Sari, Habib Laksmana Prima and Faishal Hanif 2026. Neuroprotective and Disease-Modifying Potential of GLP-1 Receptor Agonists in Parkinson’s Disease: A systematic Review of randomized Controlled Trials and Cohort Study. International Journal of Health Engineering and Technology. 4, 5 (Jan. 2026). DOI:https://doi.org/10.55227/ijhet.v4i5.567.